219 related articles for article (PubMed ID: 15714125)
1. Melanoma of unknown primary: experience at Massachusetts General Hospital and Dana-Farber Cancer Institute.
Katz KA; Jonasch E; Hodi FS; Soiffer R; Kwitkiwski K; Sober AJ; Haluska FG
Melanoma Res; 2005 Feb; 15(1):77-82. PubMed ID: 15714125
[TBL] [Abstract][Full Text] [Related]
2. Stage IV melanoma of unknown primary: A population-based study in the United States from 1973 to 2014.
Scott JF; Conic RZ; Thompson CL; Gerstenblith MR; Bordeaux JS
J Am Acad Dermatol; 2018 Aug; 79(2):258-265.e4. PubMed ID: 29580859
[TBL] [Abstract][Full Text] [Related]
3. Improved survival after lymphadenectomy for nodal metastasis from an unknown primary melanoma.
Lee CC; Faries MB; Wanek LA; Morton DL
J Clin Oncol; 2008 Feb; 26(4):535-41. PubMed ID: 18235114
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in 1,521 melanoma patients with distant metastases.
Barth A; Wanek LA; Morton DL
J Am Coll Surg; 1995 Sep; 181(3):193-201. PubMed ID: 7670677
[TBL] [Abstract][Full Text] [Related]
5. Metastatic melanoma to lymph nodes in patients with unknown primary sites.
Cormier JN; Xing Y; Feng L; Huang X; Davidson L; Gershenwald JE; Lee JE; Mansfield PF; Ross MI
Cancer; 2006 May; 106(9):2012-20. PubMed ID: 16568458
[TBL] [Abstract][Full Text] [Related]
6. Melanoma of unknown primary origin: a population-based study in the Netherlands.
de Waal AC; Aben KK; van Rossum MM; Kiemeney LA
Eur J Cancer; 2013 Feb; 49(3):676-83. PubMed ID: 23031553
[TBL] [Abstract][Full Text] [Related]
7. Melanoma of unknown primary site: presentation, treatment, and prognosis--a single institution study. University of Pennsylvania Pigmented Lesion Study Group.
Anbari KK; Schuchter LM; Bucky LP; Mick R; Synnestvedt M; Guerry D; Hamilton R; Halpern AC
Cancer; 1997 May; 79(9):1816-21. PubMed ID: 9129001
[TBL] [Abstract][Full Text] [Related]
8. Recurrence behavior in early-stage cutaneous melanoma: pattern, timing, survival, and influencing factors.
Tas F; Erturk K
Melanoma Res; 2017 Apr; 27(2):134-139. PubMed ID: 28099368
[TBL] [Abstract][Full Text] [Related]
9. Brain metastases in adult patients with melanoma of unknown primary in the Netherlands (2011-2020).
Padilla CS; Ho VKY; Mooijenkind TWAN; Louwman MWJ; de Vos FYFL; Bekkenk MW; Minnaard WA; Loef C; van Zanten SEMV
J Neurooncol; 2023 May; 163(1):239-248. PubMed ID: 37169949
[TBL] [Abstract][Full Text] [Related]
10. Melanoma without a detectable primary site with metastases to lymph nodes.
Rutkowski P; Nowecki ZI; Dziewirski W; Zdzienicki M; Pieñkowski A; Salamacha M; Michej W; Trepka S; Bylina E; Ruka W
Dermatol Surg; 2010 Jun; 36(6):868-76. PubMed ID: 20482725
[TBL] [Abstract][Full Text] [Related]
11. A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III).
Balch CM; Soong SJ; Murad TM; Smith JW; Maddox WA; Durant JR
J Clin Oncol; 1983 Feb; 1(2):126-34. PubMed ID: 6668496
[TBL] [Abstract][Full Text] [Related]
12. Survival of patients with visceral metastatic melanoma from an occult primary lesion: a retrospective matched cohort study.
Vijuk G; Coates AS
Ann Oncol; 1998 Apr; 9(4):419-22. PubMed ID: 9636833
[TBL] [Abstract][Full Text] [Related]
13. Melanoma patients with an unknown primary tumor site have a better outcome than those with a known primary following therapeutic lymph node dissection for macroscopic (clinically palpable) nodal disease.
van der Ploeg AP; Haydu LE; Spillane AJ; Scolyer RA; Quinn MJ; Saw RP; Shannon KF; Stretch JR; Thompson JF
Ann Surg Oncol; 2014 Sep; 21(9):3108-16. PubMed ID: 24802907
[TBL] [Abstract][Full Text] [Related]
14. Population-based validation of the National Cancer Comprehensive Network recommendations for baseline imaging workup of cutaneous melanoma.
Abdel-Rahman O
Melanoma Res; 2019 Feb; 29(1):53-58. PubMed ID: 30362976
[TBL] [Abstract][Full Text] [Related]
15. Patients undergoing lymphadenectomy for stage III melanomas of known or unknown primary site do not differ in outcome.
Hughes MC; Wright A; Barbour A; Thomas J; Smithers BM; Green AC; Khosrotehrani K
Int J Cancer; 2013 Dec; 133(12):3000-7. PubMed ID: 23754707
[TBL] [Abstract][Full Text] [Related]
16. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society.
Chang AE; Karnell LH; Menck HR
Cancer; 1998 Oct; 83(8):1664-78. PubMed ID: 9781962
[TBL] [Abstract][Full Text] [Related]
17. Extranodal Spread is Associated with Recurrence and Poor Survival in Stage III Cutaneous Melanoma Patients.
Crookes TR; Scolyer RA; Lo S; Drummond M; Spillane AJ
Ann Surg Oncol; 2017 May; 24(5):1378-1385. PubMed ID: 28130620
[TBL] [Abstract][Full Text] [Related]
18. Clinical correlates and prognostic value of different metastatic sites in patients with malignant melanoma of the skin: a SEER database analysis.
Abdel-Rahman O
J Dermatolog Treat; 2018 Mar; 29(2):176-181. PubMed ID: 28745581
[TBL] [Abstract][Full Text] [Related]
19. Improved prognosis and evidence of enhanced immunogenicity in tumor and circulation of high-risk melanoma patients with unknown primary.
Tarhini AA; Lee SJ; Tan AC; El Naqa IM; Stephen Hodi F; Butterfield LH; LaFramboise WA; Storkus WJ; Karunamurthy AD; Conejo-Garcia JR; Hwu P; Streicher H; Sondak VK; Kirkwood JM
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35074904
[TBL] [Abstract][Full Text] [Related]
20. Survival after lymphadenectomy of nodal metastases from melanoma of unknown primary site.
Gullestad HP; Ryder T; Goscinski M
J Plast Surg Hand Surg; 2023; 57(1-6):109-114. PubMed ID: 34878354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
